Clinical Trial Update: IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy [NA]

View source ↗

Summary

This clinical trial update describes the IntelliStent being studied for pulmonary flow adjustment in patients with congenital heart disease and dilated cardiomy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Dilated Cardiomyopathy
• Pulmonary Arterial Hypertension

Snippet

Sponsor: HeartPoint Global | Conditions: Pulmonary Arterial Hypertension, Dilated Cardiomyopathy | NA | Status: NOT_YET_RECRUITING